The pathogenic changes of inflammatory bowel disease (IBD)
G M Schurmann, A E Bishop, P Facer, M Vecchio, J C W Lee, D S Rampton, J M Polak Abstract The pathogenic changes of inflammatory bowel disease (IBD) depend on migration of circulating leucocytes into intestinal tissues. Although leucocyte rolling and tenuous adhesion are probably regulated by inducible selectins on vascular endothelia, little is known about the expression of these molecules in Crohn's disease and ulcerative colitis. Using immunohistochemistry on surgically resected specimens, this study investigated endothelial P-selectin (CD62, granular membrane protein-140) in frozen sections of histologically uninvolved tissues adjacent to inflammation (Crohn's disease= 10; ulcerative colitis= 10), from highly inflamed areas (Crohn's disease=20; ulcerative colitis=13), and from normal bowel (n=20). By light microscopy, two forms of P-selectin immunoreactivity were detected that apparently corresponded ultrastructurally to stored and released distributions. Compared with the normal gut, there was a 3-7-fold increase of P-selectin immunoreactivity on veins (p<0.0001), venules (p<0.0001), and capillaries (p<0.05) in the highly inflamed gut, without differences between Crohn's disease and ulcerative colitis. In the uninvolved gut, P-selectin expression was similar to that seen in normal controls, except for a focal increase of P-selectin in the vicinity of small lymphocyte aggregates. The dramatic upregulation of P-selectin in the inflamed tissue and its potential role in leucocyte trafficking support the concept of P-selectin blocking therapy for the control of active IBD. (Gut 1995; 36: 411-418) Keywords: inflammatory bowel disease, P-selectin.
The migration of leucocytes into tissues is the central event in inflammation and in an immune response. In inflammatory bowel disease (IBD), there is a dense intestinal infiltrate of inflammatory and activated immune cells with a differential distribution pattern for Crohn's disease and ulcerative colitis. For the development of the local intestinal cellular infiltrate, circulating cells must stick to the intestinal vascular endothelium and transmigrate into the tissue, where the immunoinflammatory reaction is created.
Recently, a multistep cascade of adhesion of circulating cells to endothelial cells has been proposed, entailing margination from the centreline of blood flow towards the vascular wall, rolling, tethering to the endothelia, stable adhesion, and finally, transendothelial migration. 1 Each of these steps involves specific families of adhesion molecules, which are expressed on endothelial cells and on circulating cells as their counterparts and ligands.2 3 The selectin family of adhesion molecules, which comprises E-selectin, P-selectin, and Lselectin, predominantly mediates the first steps of cellular adhesion4 5 and several studies have shown upregulation of E-selectin on activated endothelial cells in a variety of tissues6-8 including the gut in patients with IBD.9 10 Little investigation has been made, however, of Pselectin in normal and diseased gut, although its DNA was cloned and sequenced in 1989.11 In this study, we hypothesised that Pselectin is upregulated in the development of the inflammatory lesion and in active IBD.
Upregulated P-selectin could induce the adhesion of circulating inflammatory cells and thus contribute to the genesis of the intestinal cellular infiltrate.
The aim of the study therefore was to investigate qualitatively and quantitatively the expression of immunoreactive P-selectin on endothelial cells in both uninvolved and highly inflamed areas of Crohn's disease and ulcerative colitis, using light microscopy of operative Table I for further details). In all cases, diagnosis was confirmed by histopathological examination of the resected specimen. method,28 grading from '0' (non-inflamed) to '3' (highly inflamed). Only tissues without histological signs of inflammation (grade '0') were included as 'uninvolved' (Table I) .
IMMUNOCYTOCHEMISTRY
Tissue sections were immunostained using a range of antibodies (see Table II 4  0  0  0  0  0  0  0  0  0  0  0  0  4  13  1  3  0  0  0  1  0  0  0  0  0  0  0  2  9  5  4  2  0  0  0  1  0  0  0  0  0  0  0  4  4  2  5  1  0  1  0  3  2  0  0  1  2  2  3  3  0  0  3  0  7  6  7  2  5  10  10  9  5  6  17  11  3  0  7 Normal colon(n= 14) Uninvolved ulcerative colitis (n= 10) Highly inflamed ulcerative colitis (n= 13) Cap   4  0  0  0  0  0  0  0  0  0  0  0  0  0  9  0  3  0  0  0  3  1  0  0  0  0  0  0  0  10  3  0  2  0  3  2  2  2  0  0  0  3  2  0  0  3  1  8  1  0  2  2  4  2  0  0  2  3  2  0  8  0  0  3  0  14  9  10  5  9  10  10  8  4  6 In normal gut, there was sporadic endothelial expression of P-selectin in all layers of the intestinal wall without differences between ileum and colon. Vascular endothelium was more often P-selectin positive in the mucosa and submucosa than in the subserosa or muscularis propria. P-selectin immunoreactivity was mostly a feature of venules and, far less, capillaries (Table III) on arteries and only very little on arterioles and veins. P-selectin immunoreactivity in an individual vessel usually was either strong or could not be detected; only very few vessels showed weak staining. The controls were older than the disease group but there was no significant decrease in expression of endothelial Pselectin with age (control ileum rank correlation=-0.24 (p=056), control colon rank correlation=-0.10 (p=0 78)). Intravascular platelets, as identified by PECAM-1, strongly coexpressed P-selectin without an apparent difference between the groups.
P-SELECTIN IN THE UNINVOLVED GUT ADJACENT TO INFLAMMATION
In the uninvolved areas of Crohn's disease and ulcerative colitis, P-selectin showed distribution patterns and staining intensity similar to those seen in the normal gut. As in controls, immunoreactivity for P-selectin was restricted to venules, capillaries, and some veins but was not detected on arterial vessels (Table III) . Statistical evaluation of semiquantitative analysis showed no significant differences between uninvolved areas of IBD and the normal gut (Fig 1 and Fig 2) . In some vessels (<5% of all P-selectin positive vessels), P-selectin immunoreactivity appeared as small black dots and patches (Fig  3) rather than as homogeneous bands, as was usually seen (Fig 4) . The patchy distribution pattern was found on venules and, very rarely, Normal colon Uninvolved Highly inflamed Uc Uc Figure 2 : P-selectin immunoreactivity in venules in normal colon (n= 14) and in uninvolved (n= 10) and highly inflamed (n= 13) gut in ulcerative colitis (UC). on arterioles. Few small veins and venules expressed both types of P-selectin immunoreactivity within the same vessel. Staining for von Willebrand factor showed a similar and even more punctate staining pattern than that occasionally seen by staining for P-selectin ( Fig  5) suggesting that the punctate appearance of P-selectin immunoreactivity could mean colocalisation of both molecules. On ultrastructural analysis of these areas it seemed that the punctate staining pattern corresponded to Pselectin stored in Weibel-Palade bodies ( Fig  6) . In contrast, the homogeneous longitudinal immunoreactive bands seemed to correspond to P-selectin, redistributed along the endothelial cell membrane (Fig 7) . Surprisingly, both distribution patterns of P-selectin immunoreactivity could sometimes be detected within an individual endothelial cell (Fig 8) .
P-SELECTIN IN THE INFLAMED GUT
In highly inflamed areas of Crohn's disease and ulcerative colitis (grade 3), P-selectin immunoreactivity was upregulated dramatically (Table III, Fig 9) . In comparison with normal ileum, inflamed lesions of Crohn's disease showed a significant increase in Pselectin immunoreactivity score on venules (p=0.001; Fig 1, veins (p<0.0001) and capillaries (p=0 05). P-selectin was slightly, but not significantly upregulated on arteries that were positive in nine of 20 cases (Table III) . Corresponding changes were seen on veins and venules in ulcerative colitis (Fig 2) , when compared with normal colon. There were no differences in P-selectin expression between Crohn's disease and ulcerative colitis. In the inflamed gut, only very few venules showed the punctate immunoreactivity for P-selectin found in normal controls and in uninvolved IBD gut, most vessels in inflamed sections showing homogenous expression along the entire endothelial lining.
P-SELECTIN IN RELATION TO DEGREE OF INFLAMMATION
The intraindividual relation of P-selectin to grade of inflammation was studied in a further 25 specimens taken from five patients with Crohn's disease (histograde '0', n=2; '1', n=3; '2', n=11; '3', n=9) and on 24 specimens taken from five patients with ulcerative colitis (histograde '0', n=8; '1', n=8; '2', n=6; '3', n=2) (study B). P-selectin immunoreactivity seemed to be increased and became more Figure 6 : Electron micrograph of an endothelial cell in normal ileum on a section serial to that ofFig 3. P-selectin immunoreactivity is present in a cytoplasmatic granule (arrow) near the abluminal plasma membrane (original magnification x 68 000; lu=lumen). (Original magnification X 11 000; nu=nucleolus;
lu=lumen.) them coexpressed the interleukin 2 receptor, according to their state of activation. P-selectin was induced at sites of mucosal ulceration and was upregulated throughout the gut wall in cases of transmural inflammation and in the vicinity of granulomas.
Discussion This is the first comprehensive report on the endothelial expression of P-selectin in Crohn's disease and ulcerative colitis. P-selectin was highly upregulated in inflamed areas of IBD, suggesting that P-selectin may participate in the recruitment of circulating inflammatory cells into the lesion. Electron microscopic colocalisation studies using double labelling experiments with antibodies to both von Willebrand factor and P-selectin have shown that, before release, Pselectin is stored, together with von Willebrand factor, in endothelial intracellular organelles known as Weibel-Palade bodies. 12 After stimulation, intracytoplasmic Weibel-Palade bodies migrate to the cell membranes and fuse with the membrane to degranulate and allow Pselectin to redistribute along the endothelial cell surface.'2 In our tissues, although intense black P-selectin immunoreactivity prohibited the visualisation of tubular morphology characteristic for Weibel-Palade bodies at the electron microscopic level,34 the typical shape and intracellular localisation of the P-selectin immunoreactive organelles left little doubt that they were Weibel-Palade bodies. This finding and the electron microscopic demonstration of In IBD, perhaps surprisingly, no significant upregulation of P-selectin was shown in histologically non-inflamed tissues, adjacent to inflamed lesions. Given the susceptibility of any segment of the gastrointestinal tract to be affected by Crohn's disease and the continuous spread of ulcerative colitis, areas in the vicinity of inflammation will probably become inflamed in the later course of disease and thus may be regarded as 'early lesions'. We and others have shown that these areas, although lacking evidence of inflammation by cell infiltrates, are not entirely normal, displaying, for example, changed distribution of vasoactive intestinal polypeptide containing nerves35 and increased mucus production.36 Furthermore, increased expression of major histocompatibility complex antigens on nerve bundles37 and endothelial cells38 and upregulated lymphocyte function associated antigen-i on mononuclear cells31 point to immunoactivation in the vicinity of IBD lesions.
Although the regulators of P-selectin expression are not yet fully understood, most of the known stimulants are produced by macrophages (for example, histamine, tumour necrosis factor a, oxygen radicals), granulocytes (leukotriene C4, oxygen radicals) or T cells (tumour necrosis factor a), none of which occur in high numbers in uninvolved areas of intestine. Unchanged expression of P-selectin in these tissues may thus result from a lack of appropriate stimulants. Another factor that may explain the unchanged expression of P-selectin in early lesions may be the time course of its release. Pselectin appears on the cell surface of endothelial cells five to 30 minutes after stimulation but, in cultures, disappears five to 10 minutes later in the absence of neutrophils.39 Thus, it may not have been possible to detect increased expression of P-selectin if it happens less often in the early lesion than in advanced disease.
In the highly inflamed gut, we found an increased expression of endothelial P-selectin in confirmation of preliminary findings by Nakamura et al. 27 Although our study was based on morphological findings, some functional implications can be drawn. Upregulation of P-selectin immunoreactivity was mostly a feature of (postcapillary) venules -that is, the important sites of leucocyte migration in inflammation.40 As the mediation of cell adhesion is the only function of Pselectin established so far, increased P-selectin is probably involved in the recruitment of various circulating inflammatory cells into the IBD lesion; neutrophils, basophils, eosinophils, natural killer cells, and monocytes all have been shown to bind to endothelial Pselectin.13-15 17 Specifically, as T lymphocytes represent a major proportion of the cellular infiltrate in IBD and bind to P-selectin,16 Pselectin could mediate recirculation of these cells, which, after local intestinal antigen stimulation, proliferate elsewhere and migrate back to the intestinal lesion. Subsequent reciprocal interaction between endothelium and circulating cells -that is, induction of P-selectin on endothelial cells by stimulants released from inflammatory cells and recruitment of inflammatory cells into the lesion by endothelial Pselectin -could result in a self perpetuating vicious circle leading to the development of the inflammatory infiltrate. Further indirect evidence for the participation of endothelial Pselectin in intestinal cell adhesion in IBD derives from its coexpression with intercellular adhesion molecule-i (ICAM-1) found in our previous study31 and by others.2741 ICAM-1 mediates steps of the adhesion cascade subsequent to those mediated by P-selectin.4 Given the high constitutive expression of endothelial ICAM-1 in the gut,3' however, upregulation of ICAM-1 in IBD is less dramatic in comparison with that seen for P-selectin. Thus, in active disease, continuous migration of circulating cells into the inflamed tissue is essentially mediated by P-selectin and may contribute to the maintenance and spread of inflammation.
Recent evidence exists for possible additional functions of P-selectin. Blocking the molecule's action showed that P-selectin mediates vascular permeability and haemorrhage after intravenous administration of cobra venom factors in rats42 and participates in tissue necrosis and oedema after transection and replantation of the rabbit ear.43 P-selectin also contributes to the pulmonary microvascular dysfunction seen after intestinal ischaemia/reperfusion. 44 Although some of these effects may be caused by P-selectin released from activated platelets,12 the dramatic upregulation of endothelial P-selectin seen in active disease may contribute to various pathological events in IBD, either by local action, or, systemically, by shedding of the molecule. 45 Interrupting cellular recruitment into the lesion in IBD is an important therapeutic aim. Preliminary experimental data show that cellular adhesion can be blocked by monoclonal antibodies against adhesion molecules. For example, local systemic application of antibodies against lymphocyte function associated antigen-i in animals significantly reduces the cellular infiltrate and tissue damage in cardiac46 and intestinal47 ischaemia reperfusion injury and in experimental rat colitis.48 For P-selectin, application of a monoclonal antibody significantly decreases adherence of polymorphonuclear cells to stimulated endothelial cells and protects feline heart in myocardial ischaemia and reperfusion injury.49 In rats, endotoxin induced neutropenia and polymorphonuclear cell accumulation in tissues can be blocked by treatment with antibodies to P-selectin.50 Infusion of sialyl-Lewis X, a ligand for P-selectin, significantly reduces lung injury and diminishes the tissue accumulation of neutrophils in a P-selectin dependent model of rat lung injury.51 The dramatic increase of P-selectin in active IBD shown in this study supports the concept that blockade of Pselectin may have a therapeutic use in Crohn's disease and ulcerative colitis. 
